Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF

Oct. 6, 2000

Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis

Oct. 6, 2000

DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme

Oct. 6, 2000

NeoRx's skeletal targeted radiotherapy progresses to phase III

Oct. 6, 2000

Arimidex does not compromise subsequent treatment of breast cancer with tamoxifen

Oct. 6, 2000

Antileukemia immune response identified

Oct. 6, 2000

Intranasal IM-862 enters phase III

Oct. 5, 2000

Vascular-damaging combretastatin derivatives and their use in treating tumors

Oct. 5, 2000

MorphoSys and ImmunoGen begin human antibodies alliance

Oct. 5, 2000

Schering scientists disclose new antitumor epothilone derivatives

Oct. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...